Previous 10 | Next 10 |
home / stock / mgnx / mgnx articles
On Thursday, MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo) that ...
LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investiga...
U.S. stocks traded higher this morning, with the Dow Jones index jumping over 100 points on Friday. Following the market opening Friday, the Dow tr...
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday. Shares of Akamai Technologies, Inc. (NASDAQ:...
ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufactur...
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The rev...
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-qua...
U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Shares of Simulations Plus, Inc. (NASDA...
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024 Initiation of Phase 1 study of ...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, July 03, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...
2024-05-23 20:30:04 ET BTIG analyst issues BUY recommendation for MGNX on May 23, 2024 06:39PM ET. The previous analyst recommendation was Buy. MGNX was trading at $4.63 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst reco...
2024-05-23 20:00:06 ET Kaveri Pohlman from BTIG issued a price target of $9.00 for MGNX on 2024-05-23 18:39:00. The adjusted price target was set to $9.00. At the time of the announcement, MGNX was trading at $4.63. The overall price target consensus is at $15.00 with hi...